Begin Main Content Area

Overdose death & incident reporting

Act 126 of 2020 updated the previous Methadone Death and Incident Review law to include a review of death and incidents related to FDA-approved medications as a primary, secondary or contributing factor to the death or incident. The following resources  were developed by the MDAIR Team for the reporting of medication death and incidents related to FDA-approved medications for Opioid Use Disorder (MOUD) (buprenorphine, naltrexone, or methadone) where MOUD was the cause or contributing factor to the death or incident.

Public Reporting

Members of the general public can report a death or incident involving Medications for Opioid Use Disorder (MOUD) (methadone, naltrexone, and/or buprenorphine) using this electronic form: Medication Death and Incident Review (MDAIR) Act 126. If you need further directions, you can find them at the bottom of the page titled, “MDAIR Reporting Form General Public Guide and Helpful Definitions.”

Coroner Reporting

A county coroner or medical examiner shall forward all MOUD-related death cases to DDAP's MDAIR Team for review using this electronic form: MDAIR Coroner's Drug-Related Death Report *The coroner or medical examiner is only required to submit death reports involving FDA-approved MOUD that were a cause or contributing factor to the death.


Coroners and members of the public should use the electronic forms above. If you are experiencing difficulty with the electronic filing, please report your issue to RA‐DAOD@pa.gov and/or utilize the applicable fillable form below.